TimothyM.D.SterlingMD
Infectious Disease • Nashville, TNProfessor, Medicine, Vanderbilt University School of Medicine
Dr. Sterling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1996 - 1998
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1989 - 1992
Columbia University Vagelos College of Physicians and SurgeonsClass of 1989
Certifications & Licensure
TN State Medical License 2003 - 2025
MD State Medical License 1997 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection Start of enrollment: 2001 Jun 01
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI Start of enrollment: 2019 Aug 01
Publications & Presentations
PubMed
- 41 citationsImpact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysisTimothy R. Sterling, Harold P Lehmann, Thomas R. Frieden
BMJ. 2003-03-15 - 20 citationsDiagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study.Kathrin Zürcher, Marie Ballif, Sasisopin Kiertiburanakul, Henri Chenal, Marcel Yotebieng
Journal of the International AIDS Society. 2019-09-01 - 143 citationsWeight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in ...Kassem Bourgi, Cathy A. Jenkins, Peter F Rebeiro, Frank J. Palella, Richard D. Moore
Journal of the International AIDS Society. 2020-04-01
Other
- Treatment of pulmonary tuberculosis in HIV-negative patientsSterling TR
http://www.uptodate.com/contents/treatment-of-pulmonary-tuberculosis-in-hiv-negative-patients
UpToDate, Wolters Kluwer Health - 2012-11-20 - Treatment of pulmonary tuberculosis in the HIV-infected patientSterling TR
http://www.uptodate.com/contents/treatment-of-pulmonary-tuberculosis-in-the-hiv-infected-patient
UpToDate, Wolters Kluwer Health - 2013-01-22 - Monitoring the HIV-infected patient on antituberculous medicationsSterling TR
http://www.uptodate.com/contents/monitoring-the-hiv-infected-patient-on-antituberculous-medications
UpToDate, Wolters Kluwer Health - 2012-09-28
Press Mentions
Validation Strategies Help Fill EHR Data GapsMay 2nd, 2024- Blood Test Figures in Cancer Risk for People with HIVMarch 17th, 2022
AIDS-Defining Events Increase Mortality Risk: StudyFebruary 9th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
